Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Regulatory watch Last reviewed Jul 1, 2026 Next review Jul 29, 2026 Evidence snapshot AOD-9604 was developed by Metabolic Pharmaceuticals (Australia) as a modified C-terminal fragment (residues 177-191) of human growth hormone, designed to retain lipolytic activity without growth-promoting effects
Some studies in animals suggest that the peptide could accelerate bone regeneration and improve healing in bone fractures, particularly by promoting osteoblast activity (cells responsible for bone formation)
This is why gut health optimization Dr
Only after consulting a healthcare provider
Angiogenesis and chronic inflammation: cause or consequence
US$ 28.43
US$ 23.00
US$ 24.31
US$ 24.17
![PDF] Quantification of chromatographic effects of vitamin B supplementation in urine and implications for hydration assessment](https://figures.semanticscholar.org/ae1a9b20737bab10b58b0125ce0dde9f4703c069/4-Figure2-1.png)
US$ 27.02
US$ 26.90
